Literature DB >> 22890506

Population-based estimates of neuroendovascular procedures: results of a state-wide study.

Adnan I Qureshi1, Saqib A Chaudhry, Shahram Majidi, Mikayel Grigoryan, Gustavo J Rodriguez, M Fareed K Suri.   

Abstract

BACKGROUND: The Brain Attack Coalition identified the availability of neuroendovascular procedures as an essential component of a comprehensive stroke center.
OBJECTIVE: To provide population-based estimates of neuroendovascular procedures.
METHODS: State-wide estimates of cervicocerebral angiograms, endovascular ischemic stroke treatments, carotid angioplasty and stent placements, intracranial angioplasty and stent placements, endovascular treatment of intracranial aneurysms, and endovascular treatment of intracranial arteriovenous malformations (AVMs) were obtained. We calculated the annual incidence rates of various neuroendovascular and neurosurgical procedures (per 100,000 persons). For the denominator, total persons in each year were categorized in 10-year age intervals.
RESULTS: The incidence of carotid endarterectomy (387.6 per 100,000 persons) and carotid stent placement (34.7 per 100,000 persons) peaked at 75-84 years. The incidence of aneurysm embolization also peaked in that population bracket (67.9 per 100,000 persons), yet there was a dramatic reduction in the incidence of surgical aneurysm treatment (3.6 per 100,000 persons) in those aged 75-84 years. There was a prominent reduction in the incidence of all procedures in the population aged ≥85 years, except for intravenous/intra-arterial thrombolytic use in ischemic stroke. The incidence of ischemic stroke increased almost by 50% in the population aged ≥85 years compared to those aged 75-84 years. However, the incidence of endovascular procedures for acute ischemic stroke decreased from 22.8 per 100,000 persons in the population aged 75-84 years to 13.2 per 100,000 persons in the population aged ≥85 years.
CONCLUSIONS: A marked disproportion of neuroendovascular procedures performed and disease prevalence was noted in persons aged ≥85 years, an increasing segment of the population according to recent Census.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 22890506     DOI: 10.1159/000337163

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  6 in total

1.  Endovascular treatment for acute ischemic stroke patients: implications and interpretation of IMS III, MR RESCUE, and SYNTHESIS EXPANSION trials: A report from the Working Group of International Congress of Interventional Neurology.

Authors:  Adnan I Qureshi; Foad Abd-Allah; Aitziber Aleu; John J Connors; Ricardo A Hanel; Ameer E Hassan; Haitham M Hussein; Nazli A Janjua; Rakesh Khatri; Jawad F Kirmani; Mikael Mazighi; Heinrich P Mattle; Jefferson T Miley; Thanh N Nguyen; Gustavo J Rodriguez; Qaisar A Shah; Adnan H Siddiqui; Jose I Suarez; M Fareed K Suri; Reha Tolun
Journal:  J Vasc Interv Neurol       Date:  2014-05

2.  Incidences of unruptured intracranial aneurysms and subarachnoid hemorrhage: results of a statewide study.

Authors:  Ganesh Asaithambi; Malik M Adil; Saqib A Chaudhry; Adnan I Qureshi
Journal:  J Vasc Interv Neurol       Date:  2014-09

3.  A population-based study of the incidence and case fatality of non-aneurysmal subarachnoid hemorrhage.

Authors:  Adnan I Qureshi; Nauman Jahangir; Mushtaq H Qureshi; Archie Defillo; Ahmed A Malik; Gregory T Sherr; M Fareed K Suri
Journal:  Neurocrit Care       Date:  2015-06       Impact factor: 3.210

4.  A Population-Based Study of the Incidence and Case Fatality of Intracerebral Hemorrhage of Undetermined Etiology.

Authors:  Adnan I Qureshi; Mohammad R Afzal; Ahmed A Malik; Mushtaq H Qureshi; Nauman Jahangir; M Fareed K Suri
Journal:  J Vasc Interv Neurol       Date:  2015-10

5.  Society of Vascular and Interventional Neurology (SVIN) Stroke Interventional Laboratory Consensus (SILC) Criteria: A 7M Management Approach to Developing a Stroke Interventional Laboratory in the Era of Stroke Thrombectomy for Large Vessel Occlusions.

Authors:  Tanzila Shams; Osama Zaidat; Dileep Yavagal; Andrew Xavier; Tudor Jovin; Vallabh Janardhan
Journal:  Interv Neurol       Date:  2016-02-26

6.  Validation of Stroke and Thrombolytic Therapy in Korean National Health Insurance Claim Data.

Authors:  Tai Hwan Park; Jay Chol Choi
Journal:  J Clin Neurol       Date:  2015-09-11       Impact factor: 3.077

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.